Patient Community Promise Report

Introduction

Patient clinical trial engagement by the numbers

100% Sanofi clinical studies informed by patients

28 abbreviated protocols in 2025

One of the ways we ensure studies are informed is by reviewing study protocols with patients.

The 28 abbreviated protocols we reviewed in 2025 resulted in the following optimizations:

  • 28 changes to endpoints
  • 22 changes to procedures
  • 22 changes in inclusion/ exclusion criteria
  • 20 changes to required study visits
  • 20 changes to treatment administrations
  • 18 changes in study durations

Medical consultation © Zoe Savitz

“Patient priorities are the compass guiding every development milestone at Sanofi. We systematically integrate patient experience data across all R&D activities. This ensures our medicines address what patients truly need and reflect what matters most to them and their communities.”

Vicky DiBiaso, Head of Patient Driven Medicines Development